Coral Laboratories Ltd vs Ganga Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Coral Laboratories Ltd is ₹ 489.8 as of 12 Jun 15:30 . The P/E Ratio of Coral Laboratories Ltd changed from 8.5 on March 2021 to 10.4 on March 2025 . This represents a CAGR of 4.12% over 5 yearsThe P/E Ratio of Ganga Pharmaceuticals Ltd changed from 113.9 on March 2022 to 63.6 on March 2025 . This represents a CAGR of -13.56% over 4 years The Market Cap of Coral Laboratories Ltd changed from ₹ 115.04 crore on March 2021 to ₹ 250.4 crore on March 2025 . This represents a CAGR of 16.83% over 5 yearsThe Market Cap of Ganga Pharmaceuticals Ltd changed from ₹ 4.16 crore on March 2022 to ₹ 4.92 crore on March 2025 . This represents a CAGR of 4.28% over 4 years The revenue of Coral Laboratories Ltd for the Mar '26 is ₹ 29.13 crore as compare to the Dec '25 revenue of ₹ 24.06 crore. This represent the growth of 21.07% The revenue of Ganga Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Coral Laboratories Ltd for the Mar '26 is ₹ 8.84 crore as compare to the Dec '25 ebitda of ₹ 4.38 crore. This represent the growth of 101.83% The ebitda of Ganga Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Coral Laboratories Ltd changed from ₹ 8.8 crore to ₹ 5.22 crore over 8 quarters. This represents a CAGR of -22.98% The net profit of Ganga Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Ganga Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February, 1997.
It was promoted by Navin B Doshi of the DWD Group.
To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore.
It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004.
It started the commercial production at Dehradun Plant in September, 2006. Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.

About Ganga Pharmaceuticals Ltd

Ganga Pharmaceuticals Limited was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma.
The Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietary concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95.
In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra. The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

FAQs for the comparison of Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd

Which company has a larger market capitalization, Coral Laboratories Ltd or Ganga Pharmaceuticals Ltd?

Market cap of Coral Laboratories Ltd is 174 Cr while Market cap of Ganga Pharmaceuticals Ltd is 7 Cr

What are the key factors driving the stock performance of Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd?

The stock performance of Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd?

As of June 14, 2026, the Coral Laboratories Ltd stock price is INR ₹489.8. On the other hand, Ganga Pharmaceuticals Ltd stock price is INR ₹12.0.

How do dividend payouts of Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd compare?

To compare the dividend payouts of Coral Laboratories Ltd and Ganga Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.